Back to Search
Lybrel
by Wyeth Pharmaceuticals IncContraceptionCOCP
DiscontinuedReference Drug

Estrogen

Ethinyl Estradiol

0.02Mg

Progestin

Levonorgestrel

0.09Mg

Regimen Protocol

Extended Cycle Pills (no break)

Androgenicity

High

Approval Date

5/22/2007

Additives
None
Inactive Ingredients
lactose monohydratetitanium dioxidemicrocrystalline cellulosemagnesium stearatepolacrilin potassiumhypromellosepolyethylene glycol 400iron oxidepolyethylene glycol 1450montanic ester wax

Contains common allergens

Active Alternative Brands
Alternative brands with the same formulation that are actively prescribed

Teva Pharmaceuticals, Inc.

Amethyst

Ingenus Pharmaceuticals, LLC

Dolishale

Glenmark Pharmaceuticals Ltd

Levonorgestrel And Ethinyl Estradiol

Watson Laboratories Inc

Levonorgestrel And Ethinyl Estradiol

Have clinical questions about Lybrel?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy